1 month Can Roche Challenge Lilly and Novo in the Weight Loss Market?MarketBeat
One Wall Street analysts recently singled out a drug from pharma company Roche as a threat to Eli Lilly’s oral GLP-1 candidate.
XOne Wall Street analysts recently singled out a drug from pharma company Roche as a threat to Eli Lilly’s oral GLP-1 candidate.
X